Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
Thomas Zilli(University of Geneva), Claus Belka(LMU Klinikum), Jennifer Le Guévelou(Centre Eugène Marquis), Matthias Gückenberger(University Hospital of Zurich), Paul Sargos, Dominique Pasquier(Centre Hospitalier Universitaire de Grenoble), Felipe Couñago(Hospital La Luz), Vérane Achard(University of Geneva), Antonio Conde Moreno(Universidad Cardenal Herrera CEU), Alison Tree(Royal Marsden NHS Foundation Trust), S. Supiot(Institut de Cancérologie de l'Ouest), A. Zapatero(Hospital Universitario de La Princesa), Nina Schmidt-Hegemann(LMU Klinikum), Andrea Lancia(Policlinico San Matteo Fondazione), Barbara Alicja Jereczek‐Fossa(European Institute of Oncology), G. Créhange(Centre Georges François Leclerc), Piet Dirix(Iridium Kankernetwerk), Shafak Aluwini(Erasmus MC Cancer Institute), Piet Ost(Ghent University Hospital), Alfonso Gómez‐Iturriaga(BioCruces Health research Institute), Marta Scorsetti(Humanitas University), Stefano Arcangeli(Azienda Ospedaliera San Gerardo), Gianluca Ingrosso(University of Perugia), Pierre Blanchard(Inserm), Alan Dal Pra(University of Miami), Filippo Alongi(Ospedale Sacro Cuore Don Calabria)
Cited by 98
Related Papers
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
|Annals of Oncology|2021|577